Author:
Khoury Haytham,Dalal Bakul I,Nantel Stephen H,Horsman Douglas E,Lavoie Julye C,Shepherd John D,Hogge Donna E,Toze Cynthia L,Song Kevin W,Forrest Donna L,Sutherland Heather J,Nevill Thomas J
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference33 articles.
1. Erickson PF, Robinson M, Owens G, et al. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Cancer Res 1994;54: 1782–1786.
2. Lutterbach B, Westendorf JJ, Linggi B, et al. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 1998; 18:7176–7184.
3. Meyers S, Lenny N, Hiebert SW . The t(8;21) fusion protein interfers with AML-1-B-dependant transcriptional activation. Mol Cell Biol 1995;15:1974–1982.
4. Yuan Y, Zhou L, Miamoto T, et al. AML-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 2001;98:10398–10403.
5. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues. J Clin Oncol 1999;17:3835–3849.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献